Ferrier Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The mRNA-based vaccine can effectively target and stimulate protective immune cell responses against the malaria-causing parasite <em>Plasmodium</em> in preclinical models.

Trans-Tasman research collaborators from Te Herenga Waka-; Victoria University of Wellington's Ferrier Research Institute and the Malaghan Institute of Medical Research in New Zealand, and the Peter Doherty Institute for Infection and Immunity in Australia have developed an mRNA-based vaccine that can effectively target and stimulate protective immune cell responses against the malaria-causing parasite Plasmodium in preclinical models.

Hundreds of thousands of people die from malaria infection every year, but recent advances in labs around the world show promise for cutting mortality.

Business Scoop provides news and views on Business and Markets from New Zealand

Directing biosynthesis online Introduction Welcome You are warmly invited to join us online in April 2021. The Directing Biosynthesis conference has been a key meeting in the biosynthetic research calendar for over a decade and is set to be a highlight in 2021 for the community of researchers interested in the biosynthesis of natural products. Organised by the Royal Society of Chemistry, the 2021 conference will host some of the leading researchers from around the world. Networking and discussion are an important part of ...